amodiaquine has been researched along with Leishmaniasis, Visceral in 2 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Antinarelli, LMR | 1 |
Midlej, V | 1 |
da Silva, EDS | 1 |
Coelho, EAF | 1 |
da Silva, AD | 1 |
Coimbra, ES | 1 |
Nettey, H | 1 |
Allotey-Babington, GL | 1 |
Somuah, I | 1 |
Banga, NB | 1 |
Afrane, B | 1 |
Amponsah, SK | 1 |
Annor, H | 1 |
Darko, H | 1 |
Hanson, K | 1 |
Aidoo, A | 1 |
Broni, MN | 1 |
Sasu, C | 1 |
Nyarko, A | 1 |
2 other studies available for amodiaquine and Leishmaniasis, Visceral
Article | Year |
---|---|
Exploring the repositioning of the amodiaquine as potential drug against visceral leishmaniasis: The in vitro effect against Leishmania infantum is associated with multiple mechanisms, involving mitochondria dysfunction, oxidative stress and loss of cell
Topics: Amodiaquine; Animals; Antiprotozoal Agents; Cell Cycle Checkpoints; Drug Repositioning; Leishmania i | 2023 |
Assessment of formulated amodiaquine microparticles in Leishmania donovani infected rats.
Topics: Amodiaquine; Animals; Antiprotozoal Agents; Capsules; Drug Compounding; Female; Leishmania donovani; | 2017 |